Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3323706 | 1.00 | KDM4E (0.34) | KDM4EALDH1A1NPC1MAPTHPGD | |
| SCHEMBL3324288 | 0.90 | SLC6A4 (0.39) | MAPT | |
| SCHEMBL3324292 | 0.90 | SLC6A4 (0.39) | MAPT | |
| SCHEMBL3326015 | 0.87 | SLC6A4 (0.34) | ALDH1A1NPC1RAB9ACYP3A4 | |
| SCHEMBL3324790 | 0.87 | SLC6A4 (0.34) | ALDH1A1NPC1HPGDMAPK1RAB9A | |
| SCHEMBL3326013 | 0.87 | SLC6A4 (0.34) | ALDH1A1NPC1RAB9ACYP3A4 | |
| SCHEMBL3324786 | 0.87 | SLC6A4 (0.34) | ALDH1A1NPC1HPGDMAPK1RAB9A | |
| SCHEMBL3323221 | 0.86 | PPARD (0.35) | ALDH1A1CYP3A4 | |
| SCHEMBL12710229 | 0.86 | SLC6A4 (0.35) | KDM4EALDH1A1MAPTHPGDCYP1A2 | |
| SCHEMBL3323218 | 0.86 | PPARD (0.35) | ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8299302-B2 | 4-Cycloalkyl or 4-substituted phenoxyphenylamidines and use thereof as fungicides | BAYER CROPSCIENCE AG (DE) | 2012-10-30 | — | — | US | claimed |
| US-20100120615-A1 | 4-CYCLOALKYL OR 4-SUBSTITUTED PHENOXYPHENYLAMIDINES AND USE THEREOF AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2010-05-13 | — | — | US | claimed |
| EP-1969934-A1 | 4-cycloalkyl or 4-aryl substituted phenoxy phenylamidines and their use as fungicides | Bayer CropScience AG (DE) | 2008-09-17 | — | — | EP | claimed |
| US-8748662-B2 | 4-cycloalkyl or 4-aryl substituted phenoxyphenylamidines and use thereof as fungicides | BAYER CROPSCIENCE AG (DE) | 2014-06-10 | — | — | US | disclosed |
| US-20130012742-A1 | 4-CYCLOALKYL OR 4-SUBSTITUTED PHENOXYPHENYLAMIDINES AND USE THEREOF AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2013-01-10 | — | — | US | disclosed |
| US-8299302-B2 | 4-Cycloalkyl or 4-substituted phenoxyphenylamidines and use thereof as fungicides | BAYER CROPSCIENCE AG (DE) | 2012-10-30 | — | — | US | disclosed |
| US-20100120615-A1 | 4-CYCLOALKYL OR 4-SUBSTITUTED PHENOXYPHENYLAMIDINES AND USE THEREOF AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2010-05-13 | — | — | US | disclosed |
| EP-2120560-A1 | 4-CYCLOALKYL OR 4-ARYL SUBSTITUTED PHENOXYPHENYLAMIDINES AND USE THEREOF AS FUNGICIDES | Bayer CropScience Aktiengesellschaft (DE) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008110315-A1 | 4-CYCLOALKYL OR 4-ARYL SUBSTITUTED PHENOXYPHENYLAMIDINES AND USE TEHROF AS FUNGICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2008-09-18 | — | — | WO | disclosed |
| EP-1969934-A1 | 4-cycloalkyl or 4-aryl substituted phenoxy phenylamidines and their use as fungicides | Bayer CropScience AG (DE) | 2008-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100120615-A1 | 4-CYCLOALKYL OR 4-SUBSTITUTED PHENOXYPHENYLAMIDINES AND USE THEREOF AS FUNGICIDES | DDT, CYP4B1, PAH | KDM4E 291/4885ALDH1A1 763/4885NPC1 3850/4885 |
| US-20130012742-A1 | 4-CYCLOALKYL OR 4-SUBSTITUTED PHENOXYPHENYLAMIDINES AND USE THEREOF AS FUNGICIDES | DDT, CYP4B1, PAH | KDM4E 291/4885ALDH1A1 763/4885NPC1 3850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.